120 related articles for article (PubMed ID: 34137797)
1. Additional Considerations Regarding Timolol Eyedrops for Acute Treatment of Migraine.
Brar AS; Brar MK
JAMA Ophthalmol; 2021 Jun; ():. PubMed ID: 34137797
[No Abstract] [Full Text] [Related]
2. Short-term Efficacy and Safety of Topical β-Blockers (Timolol Maleate Ophthalmic Solution, 0.5%) in Acute Migraine: A Randomized Crossover Trial.
Kurian A; Reghunadhan I; Thilak P; Soman I; Nair U
JAMA Ophthalmol; 2020 Nov; 138(11):1160-1166. PubMed ID: 33001159
[TBL] [Abstract][Full Text] [Related]
3. Additional Considerations Regarding Timolol Eyedrops for Acute Treatment of Migraine-Reply.
Kurian A; Reghunadhan I; Nair U
JAMA Ophthalmol; 2021 Jun; ():. PubMed ID: 34137791
[No Abstract] [Full Text] [Related]
4. Timolol Eyedrops in the Treatment of Acute Migraine Attacks: A Randomized Crossover Study.
Cossack M; Nabrinsky E; Turner H; Abraham A; Gratton S
JAMA Neurol; 2018 Aug; 75(8):1024-1025. PubMed ID: 29799915
[TBL] [Abstract][Full Text] [Related]
5. Cardiac effects of different eyedrop preparations of timolol in rabbits.
Järvinen K; Urtti A
Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
[TBL] [Abstract][Full Text] [Related]
6. Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone.
Shimazaki J; Hanada K; Yagi Y; Yamagami J; Ishioka M; Shimmura S; Tsubota K
Br J Ophthalmol; 2000 Nov; 84(11):1250-4. PubMed ID: 11049949
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of switching to latanoprost 0.005%-timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months.
Inoue K; Okayama R; Higa R; Tomita G
Clin Ophthalmol; 2014; 8():1275-9. PubMed ID: 25061275
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy.
Inoue K; Fujimoto T; Higa R; Moriyama R; Kohmoto H; Nagumo H; Wakakura M; Tomita G
Clin Ophthalmol; 2012; 6():771-5. PubMed ID: 22693419
[TBL] [Abstract][Full Text] [Related]
9. [Systemic complications of beta-blocking eyedrops. Apropos of 6 cases].
Vinti H; Chichmanian RM; Fournier JP; Pesce A; Taillan B; Fuzibet JG; Cassuto JP; Dujardin P
Rev Med Interne; 1989; 10(1):41-4. PubMed ID: 2566193
[TBL] [Abstract][Full Text] [Related]
10. [Raynaud syndrome following timolol-containing eyedrops].
Meuche C; Heidrich H; Bleckmann H
Fortschr Ophthalmol; 1990; 87(1):45-7. PubMed ID: 2323696
[TBL] [Abstract][Full Text] [Related]
11. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
Urtti A; Rouhiainen H; Kaila T; Saano V
Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
[TBL] [Abstract][Full Text] [Related]
12. [Time course of changes in contrast sensitivity function after application of antiglaucomatous eyedrops].
Hiraoka T; Daito M; Kiuchi T; Okamoto F; Oshika T
Nippon Ganka Gakkai Zasshi; 2009 Dec; 113(12):1139-44. PubMed ID: 20058670
[TBL] [Abstract][Full Text] [Related]
13. Ocular release of timolol from molecularly imprinted soft contact lenses.
Hiratani H; Fujiwara A; Tamiya Y; Mizutani Y; Alvarez-Lorenzo C
Biomaterials; 2005 Apr; 26(11):1293-8. PubMed ID: 15475059
[TBL] [Abstract][Full Text] [Related]
14. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
Stryz JR; Merté HJ
Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
[TBL] [Abstract][Full Text] [Related]
15. Compliance with timolol treatment in glaucoma.
Rotchford AP; Murphy KM
Eye (Lond); 1998; 12 ( Pt 2)():234-6. PubMed ID: 9683946
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.
Bacon PJ; Brazier DJ; Smith R; Smith SE
Br J Clin Pharmacol; 1989 Jan; 27(1):1-5. PubMed ID: 2565117
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blocker eyedrops on corneal epithelial barrier function.
Niiya A; Yokoi N; Matsumoto Y; Komuro A; Ishibashi T; Tomii S; He J; Kinoshita S
Ophthalmologica; 2000; 214(5):332-6. PubMed ID: 10965246
[TBL] [Abstract][Full Text] [Related]
18. Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits.
Burgalassi S; Chetoni P; Panichi L; Saettone MF
J Ocul Pharmacol Ther; 1999 Feb; 15(1):1-7. PubMed ID: 10048342
[TBL] [Abstract][Full Text] [Related]
19. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
Kyyrönen K; Urtti A
J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
